Market research
033270.KO Korea United Pharm Inc
KO KRW Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 280B
- P/E ratio
- Not available
- Analyst target
- 27000
- Dividend yield
- 3.5%
- Beta
- 0.31
Community
Investor discussion
1 comment
Sign in to join the 033270.KO discussion.
5 years, 5 months ago
Korea United Pharm Inc is currently in a long term uptrend where the price is trading 5.4% above its 200 day moving average.
From a valuation standpoint, the stock is 60.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
Korea United Pharm Inc's total revenue rose by 0.3% to $57B since the same quarter in the previous year.
Its net income has dropped by 56.3% to $3B since the same quarter in the previous year.
Finally, its free cash flow grew by 5.5% to $13B since the same quarter in the previous year.
Based on the above factors, Korea United Pharm Inc gets an overall score of 4/5.